Illumina names a new CEO; the climate work happening in biotech

Taking stock of the drug industry, from the lab to the medicine chest

September 5, 2023 Check out STAT+

Sponsored By

By Ed Silverman Pharmalot Columnist, Senior Writer

Adobe STAT+ | Illumina names Agilent executive as new CEO The nomination follows a bitter board fight that ended with the departure of Francis deSouza, who had been Illumina's CEO since 2016. By Matthew Herper Republicans say they'll stop fentanyl at the border. But what are their plans for treatment? Contenders for the GOP presidential nomination stress drug interdiction on the trail, even when they have a treatment record to run on. By Lev Facher Opinion: Looking for a climate job? Consider biotech Today, many non-health sectors are turning to biotech to solve some of their biggest issues — and they're hiring. By Lily Fitzgerald Courtesy UAW 2865 STAT+ | Graduate students accuse University of California of wage theft, just months after strike was settled Grad students accuse some UC campuses of wage theft, claiming they're being credited with working fewer hours than they actually are. By Jonathan Wosen

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Pharmalot? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2023, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser